Mehmet Ali Vardar

Dysfunctional Uterine Bleeding and Other Menstrual Problems of Secondary School Students in Adana, Turkey

Cansun Demir, T.Oktay Kadayýfçý, Mehmet Ali Vardar · Journal of Pediatric and Adolescent Gynecology · 2000 · 59 citations

Medicine, Gynecology, Obstetrics +16

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

Christian Marth, Richard G. Moore, Mariusz Bidziński et al. · Journal of Clinical Oncology · 2024 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer

İsa Temur, Ümran Küçükgöz Güleç, Semra Paydaş et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2018 · 54 citations

Medicine, Hematology, Oncology +8

Durvalumab with paclitaxel/carboplatin (PC) and bevacizumab (bev), followed by maintenance durvalumab, bev, and olaparib in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) without a tumor BRCA1/2 mutation (non-tBRCAm): Results from the randomized, placebo (pbo)-controlled phase III DUO-O trial.

Philipp Harter, Fabian Trillsch, Aikou Okamoto et al. · Journal of Clinical Oncology · 2023 · 54 citations

Medicine, Oncology, Pharmacology +17

DUO-O: A randomized phase III trial of durvalumab (durva) in combination with chemotherapy and bevacizumab (bev), followed by maintenance durva, bev and olaparib (olap), in newly diagnosed advanced ovarian cancer patients.

Philipp Harter, Mariusz Bidziński, Nicoletta Colombo et al. · Journal of Clinical Oncology · 2019 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +17